Thermo Fisher Scientific Inc. [TMO] stock is trading at $620.42, up 1.49%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TMO shares have gain 0.87% over the last week, with a monthly amount glided 3.40%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Thermo Fisher Scientific Inc. [NYSE: TMO] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $670. Barclays downgraded its rating to a Equal Weight and increased its price target to $555 on January 24, 2024. Bernstein downgraded its rating to a Mkt Perform. HSBC Securities started tracking with a Buy rating for this stock on December 18, 2023, and assigned it a price target of $610. In a note dated December 13, 2023, Wolfe Research initiated an Outperform rating and provided a target price of $575 on this stock.
Thermo Fisher Scientific Inc. [TMO] stock has fluctuated between $415.60 and $622.30 over the past year. Currently, Wall Street analysts expect the stock to reach $646.05 within the next 12 months. Thermo Fisher Scientific Inc. [NYSE: TMO] shares were valued at $620.42 at the most recent close of the market. An investor can expect a potential return of 4.13% based on the average TMO price forecast.
Analyzing the TMO fundamentals
Thermo Fisher Scientific Inc. [NYSE:TMO] reported sales of 42.35B for the trailing twelve months, which represents a drop of -1.37%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.13 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 615.59 points at the first support level, and at 610.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 623.75, and for the 2nd resistance point, it is at 627.09.
Ratios To Look Out For
For context, Thermo Fisher Scientific Inc.’s Current Ratio is 1.72. As well, the Quick Ratio is 1.37, while the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 5.60, the price to book ratio is 5.00 and price to earnings (TTM) ratio is 38.48.
Transactions by insiders
Recent insider trading involved CASPER MARC N, Chairman & CEO, that happened on Sep 03 ’24 when 10000.0 shares were sold. Chairman & CEO, CASPER MARC N completed a deal on Sep 04 ’24 to sell 10000.0 shares. Meanwhile, Officer CASPER MARC N bought 10000.0 shares on Sep 04 ’24.
